Soulbrain completed the acquisition of an 80% stake in PixCell Medical for $33m.

Soulbrain, a firm engaged in the business of supplying chemical materials and battery materials, completed the acquisition of an 80% stake in PixCell Medical, a manufacturer of blood count testing diagnostics equipment, for $33m. "We identified PixCell Medical as a company proven to have disruptive technology in the healthcare field and are proud to have them join the Soulbrain family. Striving to acquire technologies that will serve as the foundation of future industry development is our focus, and we have diversified our business portfolio to include distribution of specialized diagnostic reagents and miniaturized medical devices focused on point-of-care. Providing higher added value and satisfaction to our customers is our top priority, and PixCell is a great addition to our growing family of competitive life science daughter companies," Nam Huh, Soulbrain Head of Bio-Healthcare Division and Vice President.